We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · November 19, 2020

CV Effects of Biological vs Conventional Synthetic DMARDs in Early Rheumatoid Arthritis

Annals of the rheumatic diseases


Additional Info

Annals of the rheumatic diseases
Cardiovascular Effects of Biological Versus Conventional Synthetic Disease-Modifying Antirheumatic Drug Therapy in Treatment-Naïve, Early Rheumatoid Arthritis
Ann. Rheum. Dis 2020 Nov 01;79(11)1414-1422, S Plein, B Erhayiem, G Fent, S Horton, RB Dumitru, J Andrews, JP Greenwood, P Emery, EM Hensor, P Baxter, S Pavitt, MH Buch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading